iStent® Trabecular Micro-Bypass Stent Reduced IOP and Medication Use in Predominately Hispanic Glaucoma Patient Population, According to Published Study
TMCnet.com,
] Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization…